Keep Close Watch On ALDX Today, ABBV Just Hit Another High, Fennec Uplisted

Today's Daily Dose brings you news about AbbVie's SELECT-BEYOND trial results; Aldeyra's clinical trial catalyst to watch out for today; Fennec's uplisting; Peregrine's quarterly results; Pulse Bio's withdrawal of 510(k) for PulseTx System and appointment of a new CEO at TEVA.

from RTT - Biotech http://ift.tt/2jhVGPq
via IFTTT